CD4 and AIDS: Though HIV/AIDS clinical guidelines did not recommend ART initiation for all HIV-seropositive patients during this study period, treatment for individuals with a CD4 count at or below 350 cells/mm3 shifted from a moderate to strong recommendation over this time period [13, 14].